Clinical Pharmacokinetics of Novel Biopharmaceuticals
Received Date: Jun 04, 2024 / Published Date: Jun 28, 2024
Abstract
Biopharmaceuticals, including monoclonal antibodies, fusion proteins, and therapeutic peptides, have emerged as pivotal therapies in modern medicine due to their targeted efficacy and reduced side effects compared to traditional drugs. Understanding their clinical pharmacokinetics is crucial for optimizing therapeutic outcomes and ensuring patient safety. This review explores the absorption, distribution, metabolism, and excretion (ADME) of novel biopharmaceuticals, highlighting factors influencing their pharmacokinetic profiles and clinical implications. Insights into biopharmaceutical pharmacokinetics inform dosing strategies, therapeutic monitoring, and the development of personalized medicine approaches
Citation: Kudirat TT (2024) Clinical Pharmacokinetics of Novel Biopharmaceuticals.Clin Pharmacol Biopharm, 13: 459.
Copyright: © 2024 Kudirat TT. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open 91桃色 Journals
Article Usage
- Total views: 1143
- [From(publication date): 0-2024 - Aug 24, 2025]
- Breakdown by view type
- HTML page views: 907
- PDF downloads: 236
